The largest database of trusted experimental protocols

22 protocols using adju phos

1

Immunization of New Zealand White Rabbits

Check if the same lab product or an alternative is used in the 5 most similar protocols
New Zealand White female rabbits of 3 to 4 months of age were obtained from a specific pathogen-free colony (Labcorp Drug Development, Princeton, NJ, USA). Animals were housed individually in a Merck animal facility, in accordance with the Guide for the Care and Use of Laboratory Animals, and the facility is credentialed by the Association for Assessment and Accreditation of Laboratory Animal Care [36 (link)]. Groups of rabbits (N = 4) were immunized at weeks 0, 3, and 8 with intramuscular injections of 20 μg of various proteins in the presence of 90 μg Adju-Phos (Brenntag, Ballerup, Denmark), as well as a control group of Adju-Phos alone in 0.5 mL saline, and the immune sera were collected at weeks 0, 5, and 10.
+ Open protocol
+ Expand
2

Immunization Protocol for β-Gal Antigen

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals (n = 10) were immunized 3 times at day 0, 14, and 28 by intramuscular route. Each animal received a dose of 50 μl containing 15 μg of β-Gal protein (Sigma-Aldrich, Germany) as antigen. ß-Gal was either adsorbed to alum [1:1 v/v, aluminum hydroxyphosphate (Adju-Phos®), Brenntag Biosector, Denmark] at pH 7.4 and 25°C or co-administered with c-di-AMP (Biolog, Germany) at a concentration of 5 μg per dose. Fourteen days after the third immunization, spleens of vaccinated mice were collected, immune cells were extracted, pooled and restimulated with β-Gal. The cytokine concentration was measured by cytometric bead array (CBA). Results from one representative out of two independent experiments are shown.
+ Open protocol
+ Expand
3

Synthetic Aβ Immunogens for UB-311 Vaccine

Check if the same lab product or an alternative is used in the 5 most similar protocols
UBITh®1–14 peptide immunogens for the UB-311 vaccine product and Aβ peptide antigens for immunoassays were synthesized using automated solid-phase synthesis, purified by preparative high performance liquid chromatography (HPLC), and characterized by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometer, amino acid analysis, and reverse-phase HPLC. UB-311 comprises two Aβ1–14–targeting peptides (B-cell epitope), each synthetically linked to different helper T-cell peptide epitopes (UBITh®), and formulated in an alum-containing Th2-biased delivery system (US patent no. 9,102,752). The two Aβ immunogens are the cationic Aβ1–14-εK-KKK-MvF5 Th [ISITEIKGVIVHRIETILF] and Aβ1–14-εK-HBsAg3 Th [KKKIITITRIITIITID] peptides, in equimolar ratio; they were mixed with polyanionic CpG oligodeoxynucleotide (ODN) to form stable immunostimulatory complexes of micron-size particulates, to which aluminum mineral salt (Adju-Phos, Brenntag Biosector, Denmark), was added to the final formulation, along with sodium chloride for tonicity and 0.25% 2-phenoxyethanol as preservative. The vaccine product was manufactured under “good manufacture practice” (GMP) conditions at United Biomedical as sponsor (New York).
+ Open protocol
+ Expand
4

Cotton Rat Respiratory Tract Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were anesthetized as previously described [32 (link)] with isoflurane inhalation and intranasally inoculated with a fluid volume of 100μL. For bronchoalveolar lavage studies, cotton rats were inoculated with either 5μg of purified G protein, or 5μg or 20μg recombinant mouse CX3CL1 (458-MF, R&D Systems, Minneapolis, MN, USA). To determine the best serotype of AAV for studies in the cotton rat respiratory tract, cotton rats were inoculated with 109−10 DNAase resistant particles (DRP) with different serotypes of AAV expressing GFP for flow cytometry studies. Blood samples were obtained by retro-orbital bleed in isofluorane narcosis. For the studies of inflammation and immunogenicity, cotton rats were inoculated with 2x1010 DRP of various AAV constructs and challenged with 105 TCID50 of RSV A2. 100μg house dust mite (HDM, Dermatophagoides pteronyssinus) antigen was absorbed to aluminum phosphate (AdjuPhos, Brenntag, Ballerup, Denmark) at a 1:1 ratio for 30 minutes at room temperature and injected into cotton rats intraperitoneally (IP). Sensitization was followed 8 days later with intranasal administration of 100μg HDM in a volume of 100μL PBS. Four days after HDM administration, cotton rats were euthanized through CO2 inhalation and lungs were collected for histologic examination.
+ Open protocol
+ Expand
5

Guinea Pig Rotavirus Vaccine Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Outbred female Hartley guinea pigs weighing 500-550g (Charles River) were maintained under animal biosafety level 2 conditions in isolator cages. Guinea pigs were immunized IM three times at 2-week intervals with 10 or 20μg of the P[8]ΔVP8*or P2-P[8]ΔVP8*, or 20μg of P[6]ΔVP8* or P2-P[6]ΔVP8* vaccine with or without aluminum phosphate (AP) adjuvant (ADJU-PHOS®, Brenntag) (aluminum content of 100μg/dose). In a VNtAb kinetics study, guinea pigs were vaccinated IM with 10 or 20μg of P2-P[8]ΔVP8* vaccine with AP three times at 2-week intervals. Blood samples were collected prior to each immunization as well as at 7 days or 2, 4 and 6 months after the third immunization. All guinea pig experiments were conducted in compliance with the guidelines of the Institutional Animal Care and Use Committee of the National Institute of Allergy and Infectious Diseases.
+ Open protocol
+ Expand
6

Guinea Pig Chikungunya Virus VLP Vaccination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hartley guinea pigs were obtained from Charles River Laboratories. Purified CHIKV VLPs derived from infection of SfBasic with AcMNPV-CHIKV37997 and VLP standard derived from transient transfection of HEK293 cells were adjuvanted onto Adju-Phos aluminum based adjuvant (Brenntag Biosector). Guinea pigs (4 animals per group) were vaccinated intramuscularly with doses of 0.01, 0.1, 1, or 10 μg of CHIKV VLPs. Animals were vaccinated at Day 0 and Day 14, and serum was sampled on Day 14 (prior to dosing) and on Day 21 (at study completion). A pre-vaccination serum sample was taken prior to the first vaccination for the purpose of establishing the serum IgG ELISA background.
+ Open protocol
+ Expand
7

Allergic Airway Sensitization in Cotton Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
100μg house dust mite (HDM, Dermatophagoides pteronyssinus) antigen was absorbed in aluminum phosphate (AdjuPhos, Brenntag, Ballerup, Denmark) at 1:1 ratio for 30 minutes at room temperature. HDM was administered intraperitoneally (IP). Sensitization was followed 8 days later with intranasal (IN) administration of 100μg HDM in a volume of 100μL PBS. Four days after IN HDM administration, cotton rats were anesthetized and forced oscillation technique was performed or lungs were collected for histologic examination.
+ Open protocol
+ Expand
8

Quantifying RSV F Protein and PS80 Detergent

Check if the same lab product or an alternative is used in the 5 most similar protocols
RSV F/PS80 sample was spiked with Adju-Phos (Brenntag Biosector) to a 3:1 alum:protein mass ratio and incubated at room temperature for 30 min with rotational mixing. The slurry was pelleted at 3000 rpm centrifugation for 10 min. To determine the PS80 detergent concentration, the resulting supernatant was recovered and treated with molar excess sodium hydroxide to de-esterify and quantitate oleic acid by RP-HPLC-UV (absorbance detection at a 195 nm wavelength) using a Waters C18 column (Milford, MA). For RSV F protein quantitation, the supernatant was analyzed by a separate RP-HPLC-UV method (absorbance detection at a 280 nm wavelength) using an Imtakt USA C18 column (Portland, OR). Both methods utilized Agilent HPLC systems (Santa Clara, CA). Duplicate Adju-Phos treatment and quantification were performed with the RSV F formulation buffer containing 0.04% PS80 as a control sample. Detergent and protein quantification were also performed on RSV F/PS80 samples and formulation buffer samples prior to Adju-Phos treatment to establish baseline recovery values. Results for these RP-HPLC assays are provided in Table S1.
+ Open protocol
+ Expand
9

Aluminium Adjuvant Protocols and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The aluminium adjuvant preparations used in this study were Alhydrogel; AlO(OH) and Adju-Phos, Al(OH)x(PO4)y, purchased from Brenntag Biosector (Frederikssund, Denmark). Dealuminated zeolite Y (USY) was purchased from Tosoh Corporation, Japan.
Lumogallion (CAS 4386–25-8) was purchased from TCI Europe N.V., Antwerp, Belgium, and lipopolysaccharide (LPS, from Escherichia coli O111:B4) was purchased from Sigma-Aldrich, St. Louis, MO, USA.
+ Open protocol
+ Expand
10

Immunization of Murine Models with SIV Env

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six- to ten-week-old C57BL/6, B6.129S2-H2dlAb1-Ea/J (major histocompatibility complex class II [MHC-II] knockout [KO]), B6.129S2-Cd40lgtm1Imx/J (CD40L KO), and B6.129P2-Cd40tm1Kik/J (CD40 KO) mice were purchased from the Jackson Laboratory (Bar Harbor, ME). Thymectomized C57BL/6 mice underwent adult thymectomy at the Jackson Laboratory (Bar Harbor, ME). Mice were immunized intramuscularly (i.m.) with a volume of 100 μl divided between the two quadriceps. The previously described E1/E3-deleted Ad26-SIVmac239 Env or Ad5-SIVmac239 Env was used at a dose of 109 or 1010 viral particles (vp) (24 (link)). Simian immunodeficiency virus (SIV) Env 32H gp140 was used at 50 μg with 100 μg Adju-Phos (Brenntag) (25 (link)). All animal experiments were performed in accordance with Institutional Animal Care and Use Committee guidelines of the Beth Israel Deaconess Medical Center.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!